Catalyst
Slingshot members are tracking this event:
Bone Index Receives FDA 510k Clearance for the Bindex Point-of-care Instrument to Help Physicians in Diagnosing Osteoporosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| Bone Index | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bindex Point-of-care Instrument, 510(k) Clearance, Underdiagnosed Disease, Osteoporosis Diagnosis
